News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Biotech combo to make Bothell its new home
Pennsylvania-based biotech company Immunome has announced it will be relocating to Seattle following its merger with local firm Morphimmune. The partners will reside in the
Aurion doses first patients in US Phase 1/2 clinical trial
Seattle-based company Aurion Biotech announced that a subject in its Phase 1/2 clinical trial was the first to receive a dose of its corneal endothelial
Seattle ranks No. 1 in new report measuring U.S. cities on highly valued tech skills
A report from Cities on the Tech Frontier announced Seattle as the American city with the best technology talent, placing it above hubs like Silicon
Lumen Bioscience secures DOD funding for infection treatment
Seattle-based biotech company Lumen Bioscience received $16.2 million from the U.S. Department of Defense to support the development of its C. difficile treatment. The award
Pfizer wins unconditional EU antitrust okay for $43 bln Seagen buy
The European Commission granted pharmaceutical giant Pfizer unconditional EU antitrust approval for its acquisition of Bothell-based biotech company Seagen. The acquisition, announced in March of
Gallery: The 10 best American cities for remote work
Seattle is the second-best city in America for remote work, according to a new ranking from CoworkingCafe. Rankings were determined by 11 metrics across categories
Seattle startup Optimize Health lands $18.6M to boost remote care software
Seattle-based Optimize Health completed its $18.6 million Series B funding round, which was led by Foundry and Escalate Capital Partners. The startup sells remote patient
Report: Shingles vaccine maker Curevo Vaccine signs lease in Bothell
Bothell-based biotech company, Curevo Vaccine, has a new home in the Seattle suburb. The shingles vaccine maker is leasing more than 13,600 square feet of
Life Science Washington Institute and Washington State Department of Commerce Award $500,000 to Life Science Startups
Life Science Washington Institute and the Washington State Department of Commerce awarded $500,000 in grants to organizations dedicated to creating innovative healthcare solutions. The grants
Avalyn Pharma raises $175M for pulmonary fibrosis treatments
Avalyn Pharma, a Seattle-based biopharma company, raised $175 million in a recent Series C funding round. Avalyn will use the funds to support development of
Cows burp out too much methane. This biotech startup is making a bovine Beano.
Seattle-based biotech company Lumen Bioscience is working to reduce atmospheric harm by reducing cows’ methane emissions. The company is developing a manufactured enzyme to prevent
Seagen’s cancer drug succeeds in ‘must-win’ trial
Bothell-based biotech company Seagen found success in a clinical trial testing a variety of cancer drugs. Roughly 1,000 participants joined the trial and some received